We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

COVID-19 Mathematical Model Reveals Innate Immunity Plays Larger Role in Controlling SARS-CoV-2 Viral Load than Adaptive Immunity

By HospiMedica International staff writers
Posted on 25 Jan 2021
Researchers have developed a mathematical model of SARS-CoV-2 infection that reveals a key role for the innate immune system in controlling viral load.

The mathematical model was developed by researchers at Houston Methodist (Houston, TX, USA) and predicts the viral load over time in organs that express the ACE-2 receptor, which is necessary for SARS-CoV-2’s entry into cells. The researchers aimed to improve upon the existing models for investigating virus-host interactions to simulate the whole-body dynamics of SARS-CoV-2 infection. Some of the parameters used in the model, such as the levels of various immune cells in the human body, were already known, whereas others, such as the infection rate of target cells, were estimated from published experimental data from COVID-19-infected hamsters.

Image: COVID-19 Mathematical Model Reveals Innate Immunity Plays Larger Role in Controlling SARS-CoV-2 Viral Load than Adaptive Immunity (Photo courtesy of vladdon/Shutterstock.com)
Image: COVID-19 Mathematical Model Reveals Innate Immunity Plays Larger Role in Controlling SARS-CoV-2 Viral Load than Adaptive Immunity (Photo courtesy of vladdon/Shutterstock.com)

Once the team had developed a simplified model, they used human data to make a more complete one that also included adaptive immunity. When the researchers used the model to simulate different conditions, they found that innate immunity played a larger role in controlling viral load than adaptive immunity, and that it was important to begin antiviral or interferon therapy as soon as possible after the onset of symptoms.

Related Links:
Houston Methodist


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Glassware Washer
Tiva 10-1VL

Latest COVID-19 News

Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles

World's First Inhalable COVID-19 Vaccine Approved in China

COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles